MiMedx Group, Inc. (MDXG) vs Solid Biosciences Inc. (SLDB)
A side-by-side comparison of MiMedx Group, Inc. and Solid Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDXG
MiMedx Group, Inc.
$4.60HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
SLDB
Solid Biosciences Inc.
$6.93HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — MDXG vs SLDB
growth of $100 · dividends reinvested · last 9yMDXG -69.8% (-12.5%/yr)SLDB -97.9% (-35.0%/yr)MDXG compounded faster over this window
Log scale — wide-divergence pair
MDXG SLDB
MDXG vs SLDB: by the numbers
- •SLDB is the larger company ($682M vs $670M market cap).
- •MDXG is profitable (1.76% net margin) while SLDB runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | MDXG | SLDB |
|---|---|---|
| P/E ratio | 114.88 | N/A |
| P/S ratio | 1.89 | N/A |
| P/B ratio | 3.10 | 1.82 |
| EV / EBITDA | 26.24 | N/A |
| FCF yield | 6.06% | N/A |
Profitability
| Metric | MDXG | SLDB |
|---|---|---|
| Gross margin | 78.85% | 0.00% |
| Operating margin | 15.26% | 0.00% |
| Net margin | 1.76% | 0.00% |
| ROE | 2.89% | -55.36% |
| ROIC | 1.97% | -54.12% |
Growth (annualized)
| Metric | MDXG | SLDB |
|---|---|---|
| Revenue CAGR (5Y) | 6.36% | N/A |
| Total return CAGR (5Y) | -4.94% | -27.50% |
Frequently asked
- Is MDXG or SLDB more profitable?
- MDXG runs the higher net margin — MDXG at 1.76% versus SLDB at 0.00%.
- How have MDXG and SLDB total returns compared?
- Over the past 5 years, MDXG delivered -4.94% and SLDB delivered -27.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioMiMedx ROESolid Biosciences ROEMiMedx operating marginSolid Biosciences operating marginMiMedx revenue growthSolid Biosciences revenue growthMiMedx free cash flowSolid Biosciences free cash flow
MiMedx & Solid Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.